Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study.
BMC Pharmacol Toxicol
; 14: 14, 2013 Feb 28.
Article
en En
| MEDLINE
| ID: mdl-23448278
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Sulfonamidas
/
Receptores CCR4
/
Indazoles
Tipo de estudio:
Clinical_trials
/
Prognostic_studies
Límite:
Adult
/
Aged
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
BMC Pharmacol Toxicol
Año:
2013
Tipo del documento:
Article
Pais de publicación:
Reino Unido